Mologic is a UK registered biotechnology company and manufacturer of rapid diagnostic tests that identified the opportunity to develop Covid 19 rapid testing kits in Senegal through a partnership with the famous Institut Pasteur de Dakar.

The consortium planned to set-up a dedicated unit for mega volume manufacturing of rapid tests specifically for epidemics such as Covid 19 and a range of tropical diseases such as malaria, ebola, dengue fever for the Senegalese, African and export markets.

From March to June 2020, Manufacturing Africa provided a team of analysts to support the BSR by providing structure and systems, conducting deep stakeholder consultations, drawing on global COVID-19 response expertise and conducting detailed analysis to support and accelerate fact-based decision-making at Cabinet level.